ArticleInfectious diseases and therapy2026

Efficacy and Safety of Switching to Dolutegravir/Lamivudine in Virologically Suppressed HIV-1 Infected Adults with TDF-Related Renal or Bone Toxicity.

Zhenyan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.